JUL 15, 2016 9:43 AM PDT

Treatment With Protein S Helps Alleviate Diabetes in Mice

WRITTEN BY: Carmen Leitch
Publishing in the journal Diabetes, investigators have found that protein S, a molecule made by endothelial cells, could aid in the prevention of beta cell death in diabetes.
As explained in the video above, diabetes is a serious worldwide health problem, and the number of cases is projected to rise from around 285 million in 2010 to about 400 million by 2030. Diabetes is also the fourth leading cause of death globally. There are two major forms of the disease; type 1 indicates that the body doesn’t produce insulin, and in type 2, the body either cannot properly utilize or makes too little insulin. The problems with insulin in both types of diabetes can be traced back to the death of pancreatic beta cells: vital cells that both create and regulate insulin in the body.

While medications have been made that help manage diabetes, no therapy exists that cures it. Over time, the disease can be detrimental to multiple organ systems including the eyes, kidneys, nerves and heart.

Now, Isaac Cann, a professor of animal sciences and microbiology at the University of Illinois, has collaborated with researchers at Mie University School of Medicine in Japan to demonstrate that protein S is reduced in people with diabetes. They show that protein S supplementation can help ameliorate the effects of the disease by reducing death in the beta cells.
Mice altered genetically to make more protein S (hPS-TG) mice showed less apoptosis of islet ?-cells. As the insulin (green) stained area decreased, the area of glucagon (red) staining was significantly increased in the WT/ Streptozotocin (induces beta cell death) group compared with the WT/Saline Control group but remained unchanged in the hPS TG/ Streptozotocin compared with the saline-treated group / Credit: Diabetes
"A significant problem of diabetes is the death of the beta-cells which of course, produce insulin. Type 1 diabetes is mostly genetic, whereas type 2 is basically lifestyle-related, but the progression of diabetes is the same," Cann says. "We know that in each case there is apoptosis [death] of these cells that produce insulin. So this study is really looking at how to prevent this cell death. Irrespective of the type of diabetes, if protein S is actually able to prevent death of the cells that produce insulin, then of course it is going to help in both cases.

"And so by finding that this protein, which is actually made by humans, suppresses the death of these cells is really a major finding. Maybe supplementation of this particular protein can help alleviate the progression of the disease."

Protein S regulates inflammation and cell destruction or cell death.The researchers wanted to compare the development of diabetes in mice that were altered genetically to produce extra protein S, or were given protein S after developing diabetes.

They observed significant improvements in diabetic symptoms - blood glucose levels, glucose tolerance, insulin sensitivity, as well as less severe kidney damage in both protein S mice and mice that had been supplemented with protein S.

Since the level of protein S circulating in the blood is reduced in diabetics, the scientists were encouraged to see an impact after treatment with protein S.
Protein S, from Wikipedia
"Our bodies are very complex. Unless there is another protein that degrades that protein S--which in that case, this sort of treatment is not going to work-- we thought that perhaps boosting or administering protein S could work. We did not see degradation of protein S, at least in a mouse. If you administer it directly or increase the level, you see the good effect. So perhaps if you give it to humans, it will not be degraded and it will prevent the death of cells that make insulin," Cann explains.

Cann adds that it may take time before any treatment could be made available to patients, but that there is now enough evidence to prompt researchers to move forward with protein S.
"We think this is just a first step for these collaborations. We will also be bringing in our knowledge of the microbiome to work on diabetes, and maybe find some new solutions," Cann says. "Many labs are working on this, but this is a very important contribution. Hopefully this is a concept that others will go out and test."

Sources: AAAS/Eurelalert!, Diabetes
 
 
About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAR 27, 2020
Genetics & Genomics
MAR 27, 2020
Expanding the Genomic Regions That Can Be Targeted With CRISPR
CRISPR gene-editing technology has sparked a revolution in biomedical research and is poised to have far-reaching applic ...
APR 23, 2020
Cardiology
APR 23, 2020
Arteries Respond in Different Ways in Females and Males
Exploring Arterial Smooth Muscle Kv7 Potassium Channel Function using Patch Clamp Electrophysiology and Pressure Myograp ...
APR 26, 2020
Genetics & Genomics
APR 26, 2020
Does Poor Sleep Lead to Obesity, or is the Opposite True?
For many years, researchers have been aware of the link between obesity and poor sleep or a lack of sleep. But what come ...
MAY 06, 2020
Cell & Molecular Biology
MAY 06, 2020
SARS-CoV-2 Can Infect Intestinal Cells
Once thought to cause symptoms that primarily affect the respiratory system, there has been evidence that the virus can ...
MAY 07, 2020
Cell & Molecular Biology
MAY 07, 2020
How the Function of a Critical Immune Cell is Related to Metabolism
This work suggests that it may be possible to dampen autoimmunity or promote an immune attack on cancer through a bioche ...
MAY 22, 2020
Cell & Molecular Biology
MAY 22, 2020
Some Coral Turn Neon When Stressed
Corals are immobile animals, and coral reefs are considered to be the most diverse ecosystems in the sea.
Loading Comments...